Ex parte GELORME et al. - Page 5




          Appeal No. 97-0225                                                          
          Application No. 08/357,789                                                  


               We consider first the examiner’s rejection of claims 1,                
          6, 8 and 21 through 26 under 35 U.S.C. § 112, second                        
          paragraph, as being indefinite.  In determining whether claim               
          language runs afoul of the second paragraph of 35 U.S.C. §                  
          112, we must analyze the definiteness of the language employed              
          in claims not in a vacuum, but always in light of the                       
          teachings of the prior art and the application disclosure as                
          it would be interpreted by one possessing the ordinary level                
          of skill in the pertinent art.  In re Sneed, 710 F.2d 1544,                 
          1548, 218 USPQ 385, 388 (Fed. Cir. 1983); In re Angstadt, 537               
          F.2d 498, 501, 190 USPQ 214, 217 (CCPA 1976).  The claims are               
          deemed definite so long as they reasonably apprise one of                   
          ordinary skill in the art of their scope.  In re Warmerdam, 33              
          F.3d 1354, 1361, 31 USPQ2d 1754, 1759 (Fed. Cir. 1994).  We                 
          are mindful that the examiner has the initial burden of                     
          demonstrating indefiniteness of the claims.  In re Oetiker,                 
          977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992).                 
               The examiner initially argues (Answer, page 5) that                    
          "[t]he linking bonds for the bisacrylamide and                              
          bismethacrylamide R  groups are not shown in claim 1."                      
                             4                                                        

                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007